Johnson & Johnson
JNJ
#21
Rank
C$680.26 B
Marketcap
C$282.35
Share price
-1.39%
Change (1 day)
36.55%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): C$14.74

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is C$14.56. In 2024 the company made an earnings per share (EPS) of C$9.33 a decrease over its 2023 EPS that were of C$20.11.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.7457.93%
2024C$9.33-53.6%
2023C$20.11111.16%
2022C$9.52-13.84%
2021C$11.0541.81%
2020C$7.79-18.92%
2019C$9.6121.2%
2018C$7.931125.3%
2017C$0.65-92.23%
2016C$8.337.37%
2015C$7.76-4.16%
2014C$8.0918.1%
2013C$6.8524.88%
2012C$5.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$2.40-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.59-27.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.26-29.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$5.17-64.50%๐Ÿ‡ซ๐Ÿ‡ท France
Stryker Corporation
SYK
C$10.75-26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$5.06-65.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$28.61 96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.24-22.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$5.01-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
C$9.09-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA